Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125755881 | 12575588 | 1 | I | 201408 | 20151207 | 20160720 | 20160720 | PER | US-ASTELLAS-2016US022203 | ASTELLAS | 54.02 | YR | F | Y | 58.00000 | KG | 20160720 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125755881 | 12575588 | 1 | PS | VESICARE | SOLIFENACIN SUCCINATE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | 21518 | FORMULATION UNKNOWN | |||||||||
| 125755881 | 12575588 | 2 | SS | VESICARE | SOLIFENACIN SUCCINATE | 1 | 21518 | FORMULATION UNKNOWN | |||||||||||
| 125755881 | 12575588 | 3 | C | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | U | 0 | 1 | DF | CAPSULE | QD | ||||||
| 125755881 | 12575588 | 4 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | U | 0 | 1 | DF | TABLET | QD | ||||||
| 125755881 | 12575588 | 5 | C | FLUVIRIN /01389801/ | 2 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | |||||||||
| 125755881 | 12575588 | 6 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 125755881 | 12575588 | 7 | C | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 125755881 | 12575588 | 8 | C | MACROBID | NITROFURANTOINNITROFURANTOIN MONOHYDRATE | 1 | Unknown | U | 0 | 1 | DF | CAPSULE | Q12H | ||||||
| 125755881 | 12575588 | 9 | C | TESTOSTERONE. | TESTOSTERONE | 1 | Topical | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 125755881 | 12575588 | 10 | C | ESTRACE | ESTRADIOL | 1 | Unknown | UNK UNK, TWICE WEEKLY | U | 0 | FORMULATION UNKNOWN | BIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125755881 | 12575588 | 1 | Dysuria |
| 125755881 | 12575588 | 2 | Pollakiuria |
| 125755881 | 12575588 | 3 | Multiple sclerosis |
| 125755881 | 12575588 | 4 | Product used for unknown indication |
| 125755881 | 12575588 | 5 | Product used for unknown indication |
| 125755881 | 12575588 | 6 | Product used for unknown indication |
| 125755881 | 12575588 | 7 | Product used for unknown indication |
| 125755881 | 12575588 | 8 | Product used for unknown indication |
| 125755881 | 12575588 | 9 | Product used for unknown indication |
| 125755881 | 12575588 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125755881 | 12575588 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125755881 | 12575588 | Anxiety | |
| 125755881 | 12575588 | Bladder dilatation | |
| 125755881 | 12575588 | Bladder dysfunction | |
| 125755881 | 12575588 | Depression | |
| 125755881 | 12575588 | Fear | |
| 125755881 | 12575588 | Insomnia | |
| 125755881 | 12575588 | Pelvic pain | |
| 125755881 | 12575588 | Urinary retention | |
| 125755881 | 12575588 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125755881 | 12575588 | 1 | 201408 | 201408 | 0 | |
| 125755881 | 12575588 | 3 | 20120905 | 0 | ||
| 125755881 | 12575588 | 4 | 20130529 | 0 |